Q&A with Michael Dunn of Genentech
The latest acquisition expands Spectrum’s global capabilities, and provides enhanced resources, expertise and experience to award-winning Aurora team.
Federal regulation of data privacy and security has been on the back burner for the past two years, but key members of Congress have been working behind the scenes to frame bipartisan legislation and the FTC is gearing up. The Supreme Court’s decision overturning Roe v. Wade may put this issue front and center in Congress after the midterms.
Can decentralized and agile approaches also be applied to LTFUs and the collection of real-world evidence (RWE)? What does that look like, who’s interested in pursuing it, and what are the perceived benefits and pitfalls?
Two years of a worldwide pandemic. An endless amount of impact. Business models across all industries were stretched, accommodated, and changed forever. None more so than health and wellness. Within health and wellness, telehealth was one of the areas that saw the most change.
“Engaging patients and physicians in health decisions starts with data that helps you understand their personal health experiences and needs,” said Pat Thistlethwaite, chief experience officer at HH&Y.
The European Medicines Agency (EMA) is recommending Novavax’s COVID-19 vaccine carry a warning of the possibility of two types of heart inflammation, an added burden for a shot that has so far failed to win wide uptake.
BioSpace, GettyWhen Theranos was formed in 2003, it promised to be the end-all and be-all of medical testing, a one-stop diagnostic shop from a single finger-prick of blood. What it actually did, as the world now knows, was perpetrate fraud on a massive scale, fooling its board of directors, investors and – worst of all – the physicians and patients who trusted the company to deliver accurate test results.
The new agency will help foster health equity for multicultural patients and consumers, and focus on diversity in clinical research, culturally relevant health & wellness marketing, multicultural competence in healthcare, and concrete action to address health inequities.
In his role as a medical writer, Willis will develop disease- and treatment-related content to help Peregrine’s pharmaceutical and biotechnology clients communicate the value of their treatments, diagnostics, and medical devices.
